• R&D
    • MDS
    • GMP & PIPELINE
  • PRODUCT
  • PUBLICATIONS
  • INVESTORS
    • DISCLOSURES
    • FINANCES
    • STOCK PRICE
    • INVESTORS RELATIONS
  • PEOPLEBIO
ENGLISH KOREAN
ENGLISH KOREAN
  • R&D
    • MDS
    • GMP & PIPELINE
  • PRODUCT
  • PUBLICATIONS
  • INVESTORS
    • DISCLOSURES
    • FINANCES
    • STOCK PRICE
    • INVESTORS RELATIONS
  • PEOPLEBIO

PUBLICATIONS

PeopleBio is continuously publishing peer-reviewed research.

PUBLICATIONS

  • 2020
    Blood Amyloid-β Oligomerization as a Biomarker of Alzheimer’s Disease: A Blinded Validation Study
    Youn YC, Lee BS, Kim GJ, Ryu JS, Lim K, Lee R, Suh J, Park YH, Pyun JM, Ryu N, Kang MJ, Kim HR, Kang S, An SSA, Kim SY
  • 2020
    Association of Plasma Oligomerized Beta Amyloid with Neurocognitive Battery Using Korean Version of Consortium to Establish a Registry for Alzheimer’s Disease in Health Screening Population
    Lee JJ, Choi Y, Chung S, Yoon DH, Choi SH, Kang S, Seo D, Park K
  • 2019
    Association between increased levels of amyloid-β oligomers in plasma and episodic memory loss in Alzheimer’s disease
    Xue Meng, Tao Li, Xiao Wang, Xiaozhen Lv, Zhiyu Sun, Zhang J, Feng Su, Kang S, Kim SY, An SSA, Xin Yu, Chen Zhang, Huali Wang
  • 2019
    Blood amyloid-β oligomerization associated with neurodegeneration of Alzheimer’s disease
    Youn YC, Kang S, Suh J, Park YH, Kang MJ, Pyun J, Choi SH, Jeong JH, Park KW, Lee HW, An SSA, Jacqueline C Dominguez, Kim SY
  • 2017
    Oligomeric forms of amyloid-β protein in plasma as a potential blood-based biomarker for Alzheimer’s disease
    Wang MJ, Yi SH, Han J, Park SY, Jang J, Chun IK, Kim SE, Lee BS, Kim GJ, Yu JS, Lim K, Kang SM, Park YH, Youn YC, An SSA, Kim SY
01 02 03
PeopleBio ⓒ 2020